comparemela.com

Guided Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results

PEACHTREE CORNERS, Ga., February 20, 2024 Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final stages of completing the clinical data report that will be submitted for approval by the Chinese National Medical Products Administration (NMPA). The data quality assurance review team is being led by Dr. Sui Long, Director of the Gynecology Hospital at Fudan University and includes p

Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval

Critical Survey: Guided Therapeutics (OTCMKTS:GTHP) versus Semler Scientific (NASDAQ:SMLR)

Critical Survey: Guided Therapeutics (OTCMKTS:GTHP) versus Semler Scientific (NASDAQ:SMLR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Guided Therapeutics (OTCMKTS:GTHP) vs CONMED (NASDAQ:CNMD) Critical Analysis

CONMED (NASDAQ:CNMD – Get Rating) and Guided Therapeutics (OTCMKTS:GTHP – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, risk, analyst recommendations, valuation and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and price […]

Guided Therapeutics (GTHP) Enters Agreement to Begin Clinical Trial for US FDA Approval

Guided Therapeutics (GTHP) Enters Agreement to Begin Clinical Trial for US FDA Approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.